SHANDONG WEIGAO GP News

Weigao Co., Ltd. (01066.HK): Profitability improved month-on-month and continued to promote internationalization

guosen securitiesSep 22 00:00

Hong Kong stocks are volatile | Weigao Group (01066) fell more than 8% in the morning, with first-half revenue and profit falling below expectations. UBS Group and CICC both lowered the company's target price.

Zhitong FinanceSep 2 11:41

Weigao Co., Ltd. (01066.HK): 1H24 performance is in line with expectations, management maintains full-year guidelines

Aug 30 10:36

UBS Group: Maintains a 'buy' rating on Weigao Group (01066), with a target price of HK$7.

Zhitong FinanceAug 29 11:06

DBS Keeps Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)

TipRanksAug 29 08:20

Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$6.29 From HK$8.45, Keeps at Buy

MT NewswiresJul 22 17:41

Weigao Co., Ltd. (01066.HK): Performance is affected by the collection and epidemic prevention product base, and cash flow remains healthy and high quality

May 12 00:00

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Shandong Weigao Group Medical Polymer Co (OtherSHWGF) and Cormedix (CRMD)

TipRanksApr 9 12:35

DBS: Maintaining the “Buy” Rating of Weigao Shares (01066.HK) and reducing the target price to HK$6.4

Zhitong FinanceApr 8 14:26

Weigao Co., Ltd. (1066.HK): Performance under pressure due to collection and base figures

Apr 7 14:26

Bank Rating | Goldman Sachs: Lowering the target price of Weigao shares to HK$8.7 to maintain a “buy” rating

Gelonghui FinanceApr 3 11:08

Weigao Co., Ltd. (01066.HK): 2023 results are in line with expectations and await a steady recovery in 2024

Mar 29 08:11

Changes in Hong Kong stocks | Weigao shares (01066) fell more than 5%. The company's performance last year was clearly under pressure, and CICC lowered its profit estimates and target price

Zhitong FinanceFeb 2 15:19

Research Nuggets | CICC: Lowering the target price of Weigao shares to HK$7.5 last year's performance is clearly under pressure

Gelonghui FinanceFeb 1 11:02

Goldman Sachs: Maintaining the “Buy” Rating of Weigao Shares (01066) and reducing the target price to HK$10

Zhitong FinanceFeb 1 10:41

Weigao Co., Ltd. (01066.HK): 2023 performance is clearly under pressure, waiting for stable performance in 2024

Feb 1 08:02

Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)

TipRanksJan 7 20:16

Shandong Weigao Group Medical Polymer Co (SHWGF) Gets a Buy From Jefferies

TipRanksDec 29, 2023 20:16

Jefferies Reaffirms Their Buy Rating on Shandong Weigao Group Medical Polymer Co (SHWGF)

TipRanksDec 26, 2023 20:16

Jefferies Sticks to Its Buy Rating for Shandong Weigao Group Medical Polymer Co (SHWGF)

TipRanksDec 24, 2023 20:37